Bandingkan Harga & Kinerja Kalbe Farma Tbk (KLBF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kalbe Farma Tbk dan Organon Pharma Indonesia Tbk.: Kalbe Farma Tbk diperdagangkan di Rp735 (kapitalisasi pasar 35,34 T, volume 24 jam 108,3 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 338,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 35,34 T | 104,4 M |
Volume | 108,3 jt | — |
Lot | 1,08 jt | — |
Perputaran | 80,02 M | — |
Harga Rata-rata | 738,89 | — |
Nilai Transaksi | 80,02 M | — |
Harga Ekuilibrium Indikatif | 735 | — |
Volume Ekuilibrium Indikatif | 59,74 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
